anti-CCR2 humanized antibodies (University of Regensburg/MRC)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CCR2 humanized antibodies (University of Regensburg/MRC)
Drug Alias Namemonocyte depleting antibody (University Gottingen)monocyte depleting antibody (University Regensburg/Medical Research Council Technology)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionC-C chemokine receptor type 2 antagonists
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammationImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Göttingen
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLifearcUniversity Of RegensburgUniversity Of Göttingen +[4] 
Active IndicationsN/A
Inactive IndicationsInflammationImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A